We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Therapeutic Goods Act 1989
Approval under section 42DF for use of restricted representations by Embecta Australia Pty Ltd
I, Rowena Love, as a delegate of the Secretary to the Department of Health, Disability and Ageing, on receipt of an application from Embecta Australia Pty Ltd, have approved under section 42DF of the Therapeutic Goods Act 1989, the restricted representations described in paragraph (A), for use in advertisements for the product identified in paragraph (B).
(A)
- The therapeutic goods are intended for:
- People living with diabetes who require the administration of insulin.
- People who require the administration of insulin as a part of their diabetes management. .
(B)
- Insulin syringe, fixed-needle (ARTG 486309)
- Needle, injector, medication/vaccine (ARTG 487048) .
Dated this 8th day of July 25
Signed electronically
Rowena Love
Delegate of the Secretary to the Department of Health, Disability and Ageing
Education Policy and Guidance Section
Regulatory Compliance Branch